Abbott Laboratories Share Price Buenos Aires S.E.
Stocks
ABT
ARDEUT110608
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Buenos Aires S.E.
06/10/2026
|
5-day change | 1st Jan Change | ||
| 39,500.00 ARS | -1.89% |
|
-3.04% | -17.33% |
| 05:44pm | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 05/10 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
| Market Cap | 17TCr 2,58,48400Cr 15TCr 14TCr 13TCr 24TCr 16,43100Cr 24TCr 1,70100Cr 66TCr 8,35600Cr 64TCr 62TCr 26,86300Cr | P/E 2026 * |
28.7x | P/E 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 19TCr 2,94,91500Cr 17TCr 16TCr 15TCr 28TCr 18,74700Cr 28TCr 1,94100Cr 76TCr 9,53400Cr 73TCr 71TCr 30,64900Cr | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.5x |
| Free-Float |
86.16% | Yield 2026 * |
2.62% | Yield 2027 * | 2.79% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| ABT | End-of-day quote | |
Buenos Aires S.E.
| ABTD | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | -1.89% | ||
| 1 week | -3.04% | ||
| Current month | -1.10% | ||
| 1 month | -8.01% | ||
| 3 months | +5.22% | ||
| 6 months | +4.50% | ||
| Current year | -17.33% |
| 1 week | 38,660 |  | 40,540 |
| 1 month | 38,660 | | 42,720 |
| Current year | 30,380 | | 49,620 |
| 1 year | 30,380 | | 52,525 |
| 3 years | 19,182.5 | | 53,525 |
| 5 years | 5,360.5 | | 53,525 |
| 10 years | 145 | | 53,525 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -3.04% | - | - | 17TCr | |
| +0.80% | +0.38% | -25.42% | +2.53% | 17TCr | |
| -1.49% | -0.53% | -12.71% | +14.24% | 11TCr | |
| -0.33% | +0.77% | -24.84% | +4.02% | 11TCr | |
| -0.03% | +0.72% | -46.94% | -10.20% | 7.6TCr | |
| +0.57% | +5.98% | +3.08% | +70.91% | 6.04TCr | |
| -0.65% | +6.59% | +11.44% | +66.40% | 5.35TCr | |
| +0.31% | +0.98% | -6.12% | -32.00% | 4.91TCr | |
| -1.16% | -2.49% | -18.83% | +15.13% | 4.06TCr | |
| +1.32% | -2.02% | +28.05% | +1.76% | 3.15TCr | |
| Average | -0.25% | +0.25% | -10.26% | +14.75% | 7.77TCr | |
| Weighted average by Cap. | -0.42% | -0.04% | -16.21% | +12.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 76,39500Cr 4.49TCr 4.18TCr 3.8TCr 7.16TCr 4,85600Cr 7.21TCr 50TCr 20TCr 2,47000Cr 19TCr 18TCr 7,93900Cr | 5.45TCr 82,97900Cr 4.87TCr 4.55TCr 4.13TCr 7.78TCr 5,27500Cr 7.83TCr 55TCr 21TCr 2,68300Cr 20TCr 20TCr 8,62400Cr |
| Net income | 621.22Cr 9,45400Cr 555.06Cr 517.86Cr 470.38Cr 885.9Cr 60TCr 892.51Cr 6.22TCr 2.43TCr 31TCr 2.33TCr 2.28TCr 98TCr | 789.36Cr 12,01200Cr 705.29Cr 658.02Cr 597.69Cr 1.13TCr 76TCr 1.13TCr 7.91TCr 3.09TCr 39TCr 2.96TCr 2.9TCr 1,24800Cr |
| Net Debt | 2.39TCr 36,43000Cr 2.14TCr 2TCr 1.81TCr 3.41TCr 2,31600Cr 3.44TCr 24TCr 9.37TCr 1,17800Cr 8.99TCr 8.79TCr 3,78600Cr | 2.1TCr 31,89300Cr 1.87TCr 1.75TCr 1.59TCr 2.99TCr 2,02700Cr 3.01TCr 21TCr 8.2TCr 1,03100Cr 7.87TCr 7.7TCr 3,31400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | ARS 39,500.00 | -1.89% | 1,312 |
| 05/26/05 | ARS 40,260.00 | +1.67% | 3,091 |
| 02/26/02 | ARS 39,600.00 | +0.61% | 1,969 |
| 01/26/01 | ARS 39,360.00 | -1.45% | 475 |
| 30/26/30 | ARS 39,940.00 | -1.96% | 1,138 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
